Skip to content

Relaxation Treatment for Anxiety in Adults Aged 60 or Older

Reducing Late-Life Anxiety and Improving Functioning With Self-Directed Relaxation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02429778
Acronym
BREATHE
Enrollment
40
Registered
2015-04-29
Start date
2015-05-31
Completion date
2017-06-30
Last updated
2020-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety Disorders

Brief summary

The PI developed a self-directed program to treat late-life anxiety called Breathing, Relaxation, and Education for Anxiety Treatment in the Home Environment (BREATHE). This program consists of weekly video lessons that participants watch on digital video disc (DVD) along with weekly telephone check-ins. In BREATHE participants will learn two behavioral interventions: diaphragmatic breathing and progressive muscle relaxation (PMR). The purpose of the study is to examine whether the self-directed BREATHE program is superior to a wait list control in reducing anxiety in older adults with anxiety disorders. For those assigned to wait list control, they will be offered opportunity to participate in BREATHE treatment after 8 weeks of wait list.

Interventions

BEHAVIORALDiaphragmatic Breathing

Deep or diaphragmatic breathing is taught prior to relaxation.

BEHAVIORALProgressive Muscle Relaxation

Tensing and releasing muscle groups in a specified order to help reduce tension and anxiety.

Sponsors

VA Palo Alto Health Care System
CollaboratorFED
Brain & Behavior Research Foundation
CollaboratorOTHER
Palo Alto Veterans Institute for Research
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Behavioral Intervention (relaxation, breathing, activity engagement)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participants have a diagnosis of an anxiety disorder, specifically, Generalized Anxiety Disorder, Panic Disorder, Agoraphobia, Social Anxiety Disorder or Anxiety Disorder Unspecified/Other Specified). * Participants speak English.

Exclusion criteria

* Diagnosis of Dementia * Probable presence of significant cognitive impairment according to a brief cognitive screen * Serious mental illness (schizophrenia, psychosis, bipolar disorder)

Design outcomes

Primary

MeasureTime frameDescription
Change in Anxiety SymptomsChange from baseline to 8 weeksThe Geriatric Anxiety Scale (GAS) is a 30-item measure of somatic, cognitive, and affective symptoms of anxiety. The first 25 items of the measure are used to compute the total score; the last 5 items provide information about the content of worries or fears. Total scores range from 0 to 75 with higher scores indicating worse anxiety. Participants provide severity ratings for items using on a four-point Likert-type scale.
Change in Activity EngagementChange from baseline to 8 weeksThe Activity Card Sort contains 80 photographs that depict the performance of instrumental activities, low-physical-demand leisure activities, high-physical-demand leisure activities, and social activities. This measure will be used to assess engagement in activities. The score reported is the lifestyle-adjusted function score. It represents the percentage of activities ever completed that are perceived to be easy. Higher scores indicate greater ease of activity completion/engagement.

Secondary

MeasureTime frameDescription
Change in Depressive SymptomsChange from baseline to 8 weeksThe Patient Health Questionnaire 9-item (PHQ-9) is a 9-item depression assessment rated on a four-point Likert-type scale with scores ranging from 0 to 27. It includes one item that inquires about suicide ideation. Higher scores indicate more severe depressive symptoms. Validity and reliability have been established with primary care patients.
Change in Somatic SymptomsChange from baseline to 8 weeksSomatic Symptom Scale (SSS-8). The SSS-8 is an 8-item somatic symptom assessment rated on a five-point Likert-type scale with scores ranging from 0 to 32. The SSS-8 is administered to characterize participants' somatic symptoms. Higher symptoms indicate worse somatic symptom severity.

Other

MeasureTime frameDescription
Change in Heart RateChange from baseline to 8 weeksHeart rate will be measured at baseline and at 8 weeks after enrollment. This is an exploratory measure.
Change in Blood PressureChange from baseline to 8 weeksBlood pressure will be measured at baseline and at 8 weeks after enrollment. This is an exploratory measure.

Countries

United States

Participant flow

Participants by arm

ArmCount
BREATHE
4 weeks DVD-delivered relaxation intervention program called breathe. The experimental intervention includes progressive muscle relaxation, diaphragmatic breathing, and home practice of the skills. Following the 4 weeks of treatment, participants will be asked to continue to practice at home for 4 weeks. Diaphragmatic Breathing: Deep or diaphragmatic breathing is taught prior to relaxation. Progressive Muscle Relaxation: Tensing and releasing muscle groups in a specified order to help reduce tension and anxiety.
20
Wait List
8 week wait list period. Participants assigned to wait list will have the opportunity to receive BREATHE arm after 8 weeks if interested.
20
Total40

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up20
Overall StudyWithdrawal by Subject50

Baseline characteristics

CharacteristicWait ListTotalBREATHE
Age, Continuous69.45 years
STANDARD_DEVIATION 7.61
68.93 years
STANDARD_DEVIATION 7.13
68.40 years
STANDARD_DEVIATION 6.77
Geriatric Anxiety Scale22.90 units on a scale
STANDARD_DEVIATION 10.98
21.88 units on a scale
STANDARD_DEVIATION 9.7
20.85 units on a scale
STANDARD_DEVIATION 8.38
Patients Health Questionnaire 9-item6.80 units on a scale
STANDARD_DEVIATION 5.48
7.60 units on a scale
STANDARD_DEVIATION 5.5
8.40 units on a scale
STANDARD_DEVIATION 5.55
Race/Ethnicity, Customized
Race/Ethnicity
Asian
1 Participants5 Participants4 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Other
2 Participants2 Participants0 Participants
Race/Ethnicity, Customized
Race/Ethnicity
White/Hispanic
3 Participants5 Participants2 Participants
Race/Ethnicity, Customized
Race/Ethnicity
White/Non-Hispanic
14 Participants28 Participants14 Participants
Region of Enrollment
United States
20 participants40 participants20 participants
Sex: Female, Male
Female
13 Participants24 Participants11 Participants
Sex: Female, Male
Male
7 Participants16 Participants9 Participants
Somatic Symptom Scale 8-item8.80 units on a scale
STANDARD_DEVIATION 5.63
9.15 units on a scale
STANDARD_DEVIATION 5.15
9.50 units on a scale
STANDARD_DEVIATION 4.74

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 200 / 20
other
Total, other adverse events
0 / 200 / 20
serious
Total, serious adverse events
0 / 200 / 20

Outcome results

Primary

Change in Activity Engagement

The Activity Card Sort contains 80 photographs that depict the performance of instrumental activities, low-physical-demand leisure activities, high-physical-demand leisure activities, and social activities. This measure will be used to assess engagement in activities. The score reported is the lifestyle-adjusted function score. It represents the percentage of activities ever completed that are perceived to be easy. Higher scores indicate greater ease of activity completion/engagement.

Time frame: Change from baseline to 8 weeks

Population: A linear mixed effects model using maximum likelihood modeling was employed to analyze these data using intent-to-treat principles.

ArmMeasureGroupValue (MEAN)Dispersion
BREATHEChange in Activity EngagementBaseline49.97 units on a scaleStandard Error 3.04
BREATHEChange in Activity Engagement8 weeks54.97 units on a scaleStandard Error 3.57
Wait ListChange in Activity EngagementBaseline50.15 units on a scaleStandard Error 2.83
Wait ListChange in Activity Engagement8 weeks48.23 units on a scaleStandard Error 3.51
Primary

Change in Anxiety Symptoms

The Geriatric Anxiety Scale (GAS) is a 30-item measure of somatic, cognitive, and affective symptoms of anxiety. The first 25 items of the measure are used to compute the total score; the last 5 items provide information about the content of worries or fears. Total scores range from 0 to 75 with higher scores indicating worse anxiety. Participants provide severity ratings for items using on a four-point Likert-type scale.

Time frame: Change from baseline to 8 weeks

Population: A linear mixed effects model using maximum likelihood modeling was employed to analyze these data using intent-to-treat principles.

ArmMeasureValue (MEAN)Dispersion
BREATHEChange in Anxiety Symptoms17.95 score on a scaleStandard Error 2.34
Wait ListChange in Anxiety Symptoms26.2 score on a scaleStandard Error 2.14
Secondary

Change in Depressive Symptoms

The Patient Health Questionnaire 9-item (PHQ-9) is a 9-item depression assessment rated on a four-point Likert-type scale with scores ranging from 0 to 27. It includes one item that inquires about suicide ideation. Higher scores indicate more severe depressive symptoms. Validity and reliability have been established with primary care patients.

Time frame: Change from baseline to 8 weeks

Population: A linear mixed effects model using maximum likelihood modeling was employed to analyze these data using intent-to-treat principles.

ArmMeasureGroupValue (MEAN)Dispersion
BREATHEChange in Depressive SymptomsBaseline8.40 units on a scaleStandard Error 1.24
BREATHEChange in Depressive Symptoms8 weeks5.71 units on a scaleStandard Error 1.58
Wait ListChange in Depressive SymptomsBaseline6.80 units on a scaleStandard Error 1.23
Wait ListChange in Depressive Symptoms8 weeks8.6 units on a scaleStandard Error 1.19
Secondary

Change in Somatic Symptoms

Somatic Symptom Scale (SSS-8). The SSS-8 is an 8-item somatic symptom assessment rated on a five-point Likert-type scale with scores ranging from 0 to 32. The SSS-8 is administered to characterize participants' somatic symptoms. Higher symptoms indicate worse somatic symptom severity.

Time frame: Change from baseline to 8 weeks

Population: A linear mixed effects model using maximum likelihood modeling was employed to analyze these data using intent-to-treat principles.

ArmMeasureGroupValue (MEAN)Dispersion
BREATHEChange in Somatic SymptomsBaseline9.50 units on a scaleStandard Error 1.06
BREATHEChange in Somatic Symptoms8 weeks6.64 units on a scaleStandard Error 1.07
Wait ListChange in Somatic SymptomsBaseline8.80 units on a scaleStandard Error 1.26
Wait ListChange in Somatic Symptoms8 weeks10.30 units on a scaleStandard Error 1.28
Other Pre-specified

Change in Blood Pressure

Blood pressure will be measured at baseline and at 8 weeks after enrollment. This is an exploratory measure.

Time frame: Change from baseline to 8 weeks

Other Pre-specified

Change in Heart Rate

Heart rate will be measured at baseline and at 8 weeks after enrollment. This is an exploratory measure.

Time frame: Change from baseline to 8 weeks

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026